ÐÒÔË·Éͧ¼Æ»®

Home
Driv – Center for Research on Women’s Health

News archive for Driv – Center for Research on Women’s Health

Martha E. Hjelmeland, Jone Trovik and Camilla Krakstad are three of the researchers at the Women's Clinic at Haukeland University Hospital and the Bergen Research Group for Gynecological Cancer, who have discovered that the loss of vimentin, a protein, in preoperative biopsies can predict poor prognosis and lymph node metastasis in patients with endometrial cancer.
In a recently published study from CCBIO and Helse Bergen HF, Luka Tandaric, Line Bjørge, and her research group have investigated how immunotherapy with two specific drugs – oleclumab (anti-CD73) and durvalumab (anti-PD-L1) – affects immune cells in the blood of patients with ovarian cancer during treatment.
Each year the Norwegian Health Association (Nasjonalforeningen for folkehelsen) allocates funds for cardiovascular- and dementia research
National Institutes of Health (NIH) offers funding for women's health research internationally, and Driv encourages women's health researchers to apply. The application amount is typically up to 500 000 USD annually. There are three annual application deadlines: February 5, June 5, and October 5, until 2027. Contact Margarethe Bittens (ÐÒÔË·Éͧ¼Æ»®) for more information and for questions regarding... Read more
Researchers have a golden opportunity to contribute to creating sustainable health and care services in municipalities. Stay updated on the website and newsletters from the Research Council.
Stay updated on calls relevant to women's health research in 2025. Below is a list of calls with application deadlines starting from March.
Physical abuse and sexual assault may be linked to the development of endometriosis, a recent study shows. – Even those with a low genetic risk may be susceptible to developing the disease if they have experienced significant trauma, says lead author Solveig Løkhammer from the University of Bergen.